Literature DB >> 11907084

Uncoupling of proliferation and Stat5 activation in thymic stromal lymphopoietin-mediated signal transduction.

Deborah E Isaksen1, Heinz Baumann, Baohua Zhou, Sebastien Nivollet, Andrew G Farr, Steven D Levin, Steven F Ziegler.   

Abstract

Thymic stromal lymphopoietin (TSLP) is a cytokine that facilitates B lymphocyte differentiation and costimulates T cells. Previous studies have demonstrated that a functional TSLP receptor complex is a heterodimer consisting of the TSLP receptor and the IL-7R alpha-chain. TSLP-mediated signaling is unique among members of the cytokine receptor family in that activation of the transcription factor Stat5 occurs without detectable Janus kinase activation. Using a variety of biological systems we demonstrate here that TSLP-mediated Stat5 activation can be uncoupled from proliferation. We also show that the single tyrosine residue in the cytoplasmic domain of the TSLP receptor is critical for TSLP-mediated proliferation, but is dispensable for Stat5 activation. Our data demonstrate that TSLP-mediated Stat5 activation is insufficient for cell proliferation and identifies residues within the TSLP receptor complex required to mediate these downstream events.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11907084     DOI: 10.4049/jimmunol.168.7.3288

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  39 in total

1.  Human thymic stromal lymphopoietin enhances expression of CD80 in human CD14+ monocytes/macrophages.

Authors:  Reiji Hirano; Shunji Hasegawa; Kunio Hashimoto; Yasuhiro Haneda; Ayami Ohsaki; Takashi Ichiyama
Journal:  Inflamm Res       Date:  2011-01-28       Impact factor: 4.575

2.  Thymic stromal lymphopoietin (TSLP)-induced polyclonal B-cell activation and autoimmunity are mediated by CD4+ T cells and IL-4.

Authors:  Masanori Iseki; Miyuki Omori-Miyake; Whitney Xu; Xiaocui Sun; Satoshi Takaki; David J Rawlings; Steven F Ziegler
Journal:  Int Immunol       Date:  2012-01-25       Impact factor: 4.823

3.  Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling.

Authors:  Yrina Rochman; Mohit Kashyap; Gertraud W Robinson; Kazuhito Sakamoto; Julio Gomez-Rodriguez; Kay-Uwe Wagner; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-25       Impact factor: 11.205

4.  Thymic stromal lymphopoietin (TSLP) as a bridge between infection and atopy.

Authors:  Stéphane Esnault; Louis A Rosenthal; Deng-Shun Wang; James S Malter
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 5.  Contributions of nonhematopoietic cells and mediators to immune responses: implications for immunotoxicology.

Authors:  Barbara L F Kaplan; Jinze Li; John J LaPres; Stephen B Pruett; Peer W F Karmaus
Journal:  Toxicol Sci       Date:  2015-06       Impact factor: 4.849

Review 6.  TSLP in epithelial cell and dendritic cell cross talk.

Authors:  Yong-Jun Liu
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

Review 7.  Thymic stromal lymphopoietin: a new cytokine in asthma.

Authors:  Yrina Rochman; Warren J Leonard
Journal:  Curr Opin Pharmacol       Date:  2008-04-29       Impact factor: 5.547

8.  Site-directed mutagenesis reveals a unique requirement for tyrosine residues in IL-7Ralpha and TSLPR cytoplasmic domains in TSLP-dependent cell proliferation.

Authors:  Jun Zhong; Akhilesh Pandey
Journal:  BMC Immunol       Date:  2010-02-08       Impact factor: 3.615

9.  Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes.

Authors:  Hai-Chon Lee; Sung-Sang J Sung; Peter D Krueger; Yoon-Ah Jo; Hugo R Rosen; Steven F Ziegler; Young S Hahn
Journal:  Hepatology       Date:  2013-03-14       Impact factor: 17.425

10.  TSLP and IL-7 use two different mechanisms to regulate human CD4+ T cell homeostasis.

Authors:  Ning Lu; Yi-Hong Wang; Yui-Hsi Wang; Kazuhiko Arima; Shino Hanabuchi; Yong-Jun Liu
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.